一个GATA2-CDC6轴调节前列腺癌中的雄激素受体阻断诱导的衰老
Ioanna Mourkioti1, Aikaterini Polyzou1, Dimitris Veroutis1
1Department of Histology and Embryology, Molecular Carcinogenesis Group, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Journal of experimental & clinical cancer research : CR
|July 28, 2023
概括
恩扎胺治疗通过减少CDC6,这是进展的关键因素,诱导前列腺癌的衰老. 针对这个GATA2-CDC6轴,甚至在耐药癌症中也提供了治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞衰老 细胞衰老
背景情况:
- 前列腺癌进展到割抵抗性前列腺癌 (CRPC) 尽管有雄激素剥夺疗法 (ADT).
- 细胞衰老是已知的瘤进展的障碍.
- 在过渡到积极的CRPC中衰老的作用尚不清楚.
研究的目的:
- 调查衰老在雌激素敏感前列腺癌向CRPC进展中的作用.
- 为了确定分子机制调节衰老在恩扎拉胺治疗和耐药性.
主要方法:
- 用恩扎胺治疗依赖于安卓素 (LNCaP) 和独立 (C4-2B,PC-3) 的前列腺癌细胞.
- RNA测序和途径分析以确定衰老调节者.
- 在体外和体内评估细胞侵入,衰老状态和关键蛋白质表达 (CDC6,GATA2).
- GL13染色用于衰老的评估.
主要成果:
- 恩扎胺通过通过GATA2激活降低CDC6的调节,诱导雄激素敏感细胞的衰老.
- 在耐药细胞中,GATA2水平下降,导致CDC6稳定,促进表皮细胞转换为介质细胞 (EMT),并抑制衰老.
- 失去CDC6足以诱导衰老和逆转瘤特征,无论治疗反应如何.
结论:
- 一个GATA2-CDC6信号轴在敏感和耐性前列腺癌中至关重要,并相互调节.
- 获得的耐药性包括GATA2抑制,CDC6稳定,EMT恶化和衰老废除.
- 直接抑制CDC6绕过抵抗机制,逆转瘤性特征,并诱导衰老,提供了一个治疗机会.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
02:15Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
02:38The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
01:22Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K